CIPLA
Back to All Ratios
|
CIPLA Last 5 Year EV/CE History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EV/CE(x) | 2.47 | 3.04 | 2.66 | 1.53 | 1.95 |
What is the latest EV/CE ratio of CIPLA ?
Year | EV/CE |
---|---|
Mar2023 | 2.47 |
Mar2022 | 3.04 |
Mar2021 | 2.66 |
Mar2020 | 1.53 |
Mar2019 | 1.95 |
How is EV/CE of CIPLA Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2023 | 2.47 | -18.75 | |
Mar2022 | 3.04 | 14.29 | |
Mar2021 | 2.66 | 73.86 | |
Mar2020 | 1.53 | -21.54 | |
Mar2019 | 1.95 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹114,925.3 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics | |
MANKIND PHARMA | ₹91,490.4 Cr | -2.3% | 0.1% | NA | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.1% |
-4.8% |
56.4% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses